Interleukin-1 antagonizes morphine analgesia and underlies morphine tolerance

Pain

Volumn 115, Issue 1-2, 2005, Pages 50-59

  Shavit, Yehuda ^a   Wolf, Gilly ^a   Goshen, Inbal ^a   Livshits, Dina ^a   Yirmiya, Raz ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

Analgesia; Hyperalgesia; Interleukin 1; Interleukin 1 receptor antagonist (IL 1ra); Morphine tolerance; Opiates

Indexed keywords

ALPHA INTERMEDIN; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1BETA; LYSYL DEXTRO PROLYLTHREONINE; MORPHINE SULFATE; TRIPEPTIDE DERIVATIVE;

ANALGESIA; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG POTENTIATION; GENE DELETION; GENE OVEREXPRESSION; HOT PLATE TEST; HYPERALGESIA; MALE; MECHANICAL STIMULATION; MORPHINE TOLERANCE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; STIMULUS RESPONSE; TRANSGENIC MOUSE;

EID: 17044393404     PISSN: 03043959     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pain.2005.02.003     Document Type: Article

References (52)

1. A. Avital, I. Goshen, A. Kamsler, M. Segal, K. Iverfeldt, G. Richter-Levin, and R. Yirmiya Impaired interleukin-1 signaling is associated with deficits in hippocampal memory processes and neural plasticity Hippocampus 13 2003 826 834
2. W.A. Banks, S.A. Farr, and J.E. Morley Entry of blood-borne cytokines into the central nervous system: effects on cognitive processes Neuroimmunomodulation 10 2002 319 327
3. E. Celerier, C. Rivat, Y. Jun, J.P. Laulin, A. Larcher, P. Reynier, and G. Simonnet Long-lasting hyperalgesia induced by fentanyl in rats: preventive effect of ketamine Anesthesiology 92 2000 465 472
4. S.M. Crain, and K.F. Shen Acute thermal hyperalgesia elicited by low-dose morphine in normal mice is blocked by ultra-low-dose naltrexone, unmasking potent opioid analgesia Brain Res 888 2001 75 82
5. E.B. Cullinan, L. Kwee, P. Nunes, D.J. Shuster, G. Ju, K.W. McIntyre, R.A. Chizzonite, and M.A. Labow IL-1 receptor accessory protein is an essential component of the IL-1 receptor J Immunol 161 1998 5614 5620
6. J.M. Cunha, F.Q. Cunha, S. Poole, and S.H. Ferreira Cytokine-mediated inflammatory hyperalgesia limited by interleukin-1 receptor antagonist Br J Pharmacol 130 2000 1418 1424
7. M. Deciga-Campos, U.G. Lopez, M.I. Reval, and F.J. Lopez-Munoz Enhancement of antinociception by co-administration of an opioid drug (morphine) and a preferential cyclooxygenase-2 inhibitor (rofecoxib) in rats Eur J Pharmacol 460 2003 99 107
8. P.L. Faris, B.R. Komisaruk, L.R. Watkins, and D.J. Mayer Evidence for the neuropeptide cholecystokinin as an antagonist of opiate analgesia Science 219 1983 310 312
9. P.L. Faris, C.L. McLaughlin, C.A. Baile, J.W. Olney, and B.R. Komisaruk Morphine analgesia potentiated but tolerance not affected by active immunization against cholecystokinin Science 226 1984 1215 1217
10. S.H. Ferreira, B.B. Lorenzetti, A.F. Bristow, and S. Poole Interleukin-1 beta as a potent hyperalgesic agent antagonized by a tripeptide analogue Nature 334 1988 698 700
11. L.R. Gardell, R. Wang, S.E. Burgess, M.H. Ossipov, T.W. Vanderah, T.P. Malan Jr, J. Lai, and F. Porreca Sustained morphine exposure induces a spinal dynorphin-dependent enhancement of excitatory transmitter release from primary afferent fibers J Neurosci 22 2002 6747 6755
12. H. Gul, O. Yildiz, A. Dogrul, O. Yesilyurt, and A. Isimer The interaction between IL-1beta and morphine: possible mechanism of the deficiency of morphine-induced analgesia in diabetic mice Pain 89 2000 39 45
13. E.G. Gutierrez, W.A. Banks, and A.J. Kastin Blood-borne interleukin-1 receptor antagonist crosses the blood-brain barrier J Neuroimmunol 55 1994 153 160
14. G.P. Hernandez-Delgadillo, F.J. Lopez-Munoz, L.A. Salazar, and S.L. Cruz Morphine and dipyrone co-administration delays tolerance development and potentiates antinociception Eur J Pharmacol 469 2003 71 79
15. V. Holan, A. Zajicova, M. Krulova, V Blahoutova, and H. Wilczek Augmented production of proinflammatory cytokines and accelerated allotransplantation reactions in heroin-treated mice Clin Exp Immunol 132 2003 40 45
16. J.J. Idanpaan-Heikkila, G. Guilbaud, and V. Kayser Prevention of tolerance to the antinociceptive effects of systemic morphine by a selective cholecystokinin-B receptor antagonist in a rat model of peripheral neuropathy J Pharmacol Exp Ther 282 1997 1366 1372
17. H. Ikeda, B. Heinke, R. Ruscheweyh, and J. Sandkuhler Synaptic plasticity in spinal lamina I projection neurons that mediate hyperalgesia Science 299 2003 1237 1240
18. R.R. Ji, T. Kohno, K.A. Moore, and C.J. Woolf Central sensitization and LTP: do pain and memory share similar mechanisms? Trends Neurosci 26 2003 696 705
19. I.N. Johnston, E.D. Milligan, J. Wieseler-Frank, M.G. Frank, V. Zapata, J. Campisi, S. Langer, D. Martin, P. Green, M. Fleshner, L. Leinwand, S.F. Maier, and L.R. Watkins A role for proinflammatory cytokines and fractalkine in analgesia, tolerance, and subsequent pain facilitation induced by chronic intrathecal morphine J Neurosci 24 2004 9353 9365
20. B. Kest, E. Hopkins, C.A. Palmese, M Adler, and J.S. Mogil Genetic variation in morphine analgesic tolerance: a survey of 11 inbred mouse strains Pharmacol Biochem Behav 73 2002 821 828
21. M. Labow, D. Shuster, M. Zetterstrom, P. Nunes, R. Terry, E.B. Cullinan, T. Bartfai, C. Solorzano, L.L. Moldawer, R. Chizzonite, and K.W. McIntyre Absence of IL-1 signaling and reduced inflammatory response in IL-1 type I receptor-deficient mice J Immunol 159 1997 2452 2461
22. J. Lundkvist, A.K. Sundgren-Andersson, S. Tingsborg, P. Ostlund, C. Engfors, K. Alheim, T. Bartfai, K. Iverfeldt, and M. Schultzberg Acute-phase responses in transgenic mice with CNS overexpression of IL-1 receptor antagonist Am J Physiol 276 1999 R644 R651
23. J. Mao, D.D. Price, and D.J. Mayer Mechanisms of hyperalgesia and morphine tolerance: a current view of their possible interactions Pain 62 1995 259 274
24. D.J. Mayer, J. Mao, J. Holt, and D.D. Price Cellular mechanisms of neuropathic pain, morphine tolerance, and their interactions Proc Natl Acad Sci USA 96 1999 7731 7736
25. G.J. McCleane The cholecystokinin antagonist proglumide enhances the analgesic efficacy of morphine in humans with chronic benign pain Anesth Analg 87 1998 1117 1120
26. J.M. Mitchell, A.I. Basbaum, and H.L. Fields A locus and mechanism of action for associative morphine tolerance Nat Neurosci 3 2000 47 53
27. Mogil JS, Wilson SG, Bon K, Lee SE, Chung K, Raber P, Pieper JO, Hain HS, Belknap JK, Hubert L, Elmer GI, Chung JM, Devor M. Heritability of nociception I: Responses of 11 inbred mouse strains on 12 measures of nociception. Pain 1999a;80:67-82.
28. Mogil JS, Wilson SG, Bon K, Lee SE, Chung K, Raber P, Pieper JO, Hain HS, Belknap JK, Hubert L, Elmer GI, Chung JM, Devor M. Heritability of nociception II: 'Types' of nociception revealed by genetic correlation analysis. Pain 1999b;80:83-93.
29. M.F. O'Neill, C.T. Dourish, and S.D. Iversen Morphine-induced analgesia in the rat paw pressure test is blocked by CCK and enhanced by the CCK antagonist MK-329 Neuropharmacology 28 1989 243 247
30. X. Peng, D.M. Mosser, M.W. Adler, T.J. Rogers, J.J. Meissler Jr, and T.K. Eisenstein Morphine enhances interleukin-12 and the production of other pro-inflammatory cytokines in mouse peritoneal macrophages J Leukoc Biol 68 2000 723 728
31. E. Pinteaux, L.C. Parker, N.J. Rothwell, and G.N. Luheshi Expression of interleukin-1 receptors and their role in interleukin-1 actions in murine microglial cells J Neurochem 83 2002 754 763
32. J.J. Rady, and J.M. Fujimoto Confluence of antianalgesic action of diverse agents through brain interleukin(1beta) in mice J Pharmacol Exp Ther 299 2001 659 665
33. J.J. Rady, W.B. Campbell, and J.M. Fujimoto Antianalgesic action of nociceptin originating in the brain is mediated by spinal prostaglandin E(2) in mice J Pharmacol Exp Ther 296 2001 7 14
34. R.B. Raffa, J.R. Mathiasen, E.S. Kimball, and J.L. Vaught The combined immunological and antinociceptive defects of beige-J mice: the possible existence of a 'mu-repressin' Life Sci 52 1993 1 8
35. V. Raghavendra, M.D. Rutkowski, and J.A. DeLeo The role of spinal neuroimmune activation in morphine tolerance/hyperalgesia in neuropathic and sham-operated rats J Neurosci 22 2002 9980 9989
36. V. Raghavendra, F.Y. Tanga, and J.A. DeLeo Attenuation of morphine tolerance, withdrawal-induced hyperalgesia, and associated spinal inflammatory immune responses by propentofylline in rats Neuropsychopharmacology 29 2004 327 334
37. S. Roy, R.G. Charboneau, and R.A. Barke Morphine synergizes with lipopolysaccharide in a chronic endotoxemia model J Neuroimmunol 95 1999 107 114
38. B. Safieh-Garabedian, S. Poole, A. Allchorne, J. Winter, and C.J. Woolf Contribution of interleukin-1 beta to the inflammation-induced increase in nerve growth factor levels and inflammatory hyperalgesia Br J Pharmacol 115 1995 1265 1275
39. T.A. Samad, K.A. Moore, A. Sapirstein, S. Billet, A. Allchorne, S. Poole, J.V. Bonventre, and C.J. Woolf Interleukin-1beta-mediated induction of Cox-2 in the CNS contributes to inflammatory pain hypersensitivity Nature 410 2001 471 475
40. H. Schneider, F. Pitossi, D. Balschun, A. Wagner, A. del Rey, and H.O. Besedovsky A neuromodulatory role of interleukin-1beta in the hippocampus Proc Natl Acad Sci USA 95 1998 7778 7783
41. P. Song, and Z.Q. Zhao The involvement of glial cells in the development of morphine tolerance Neurosci Res 39 2001 281 286
42. R. Tehranian, S. Andell-Jonsson, S.M. Beni, I. Yatsiv, E. Shohami, T. Bartfai, J. Lundkvist, and J. Iverfeldt Improved recovery and delayed cytokine induction after closed head injury in mice with central overexpression of the secreted isoform of the interleukin-1 receptor antagonist J Neurotrauma 19 2002 939 951
43. V. Tortorici, L. Nogueira, R. Salas, and H. Vanegas Involvement of local cholecystokinin in the tolerance induced by morphine microinjections into the periaqueductal gray of rats Pain 102 2003 9 16
44. T.W. Vanderah, M.H. Ossipov, J. Lai, T.P. Malan Jr, and F. Porreca Mechanisms of opioid-induced pain and antinociceptive tolerance: descending facilitation and spinal dynorphin Pain 92 2001 5 9
45. J. Wang, R. Charboneau, S. Balasubramanian, R.A. Barke, H.H. Loh, and S. Roy The immunosuppressive effects of chronic morphine treatment are partially dependent on corticosterone and mediated by the mu-opioid receptor J Leukoc Biol 71 2002 782 790
46. L.R. Watkins, and S.F. Maier The pain of being sick: implications of immune-to-brain communication for understanding pain Annu Rev Psychol 51 2000 29 57
47. L.R. Watkins, and S.F. Maier Beyond neurons: evidence that immune and glial cells contribute to pathological pain states Physiol Rev 82 2002 981 1011
48. G. Wolf, R. Yirmiya, and Y. Shavit Impaired interleukin-1 (IL-1) signaling is associated with increased morphine sensitivity Neural Plast 9 2002 123
49. G. Wolf, R. Yirmiya, H. Bar-Hen, I. Goshen, and Y. Shavit IL-1-signaling plays an important role in the devlopment of opaite tolerance Neural Plast 10 2003 238
50. G. Wolf, R. Yirmiya, I. Goshen, K. Iverfeldt, L. Holmlund, K. Takeda, and Y. Shavit Impairment of interleukin-1 (IL-1) signaling reduces basal pain sensitivity in mice: genetic, pharmacological and developmental aspects Pain 104 2003 471 480
51. G. Wolf, R. Yirmiya, I. Goshen, K. Iverfeldt, and Y. Shavit Does IL-1 paly an anti-analgesic role in morphine analgesia? Brain Behav Immun 17 2003 215
52. R. Yirmiya, G. Winocur, and I. Goshen Brain interleukin-1 is involved in spatial memory and passive avoidance conditioning Neurobiol Learn Mem 78 2002 379 389